Patrick Daly

DocwireNews

Noting that pregnant women with obstructive sleep apnea (OSA) show an increased risk for preeclampsia, researchers led by Visasiri Tantrakul examined the impact of continuous positive airway pressure (CPAP) on preeclampsia as well as blood pressure among women with OSA and high-risk pregnancies.According to the results, which were published in Respiratory Research, their multicenter, open-label, randomized controlled trial found CPAP therapy reduced both diastolic blood pressure (DBP) and the frequency of preeclampsia, even among patients with mild-to-moderate OSA and high-risk pregnancy. CPAP therapy also induced a sustained reduction in DBP throughout the gestation period.High-risk status was defined as pregnancies with any high-risk condition, including <a href="https://docwirenews.com/post/osa-predicts-kidney-disease-in-patients-with-hypertension">chronic hypertension</a>, obesity, diabetes, or history of preeclampsia or gestational diabetes in a previous pregnancy.<h3>CPAP Improved Outcomes of Pregnancies With OSA</h3>The study enrolled 340 patients, of whom 96.5% were in their first trimester. After 30 exclusions, 153 patients were assigned to CPAP therapy and 157 were assigned to standard antenatal care. The primary end point of analysis was blood pressure during antenatal care, and the secondary end point was incidence of <a href="https://www.cdc.gov/bloodpressure/pregnancy.htm" target="_blank" rel="noopener">preeclampsia</a>.Authors noted the CPAP adherence rate was 32.7%, with an average use of 2.5 hours per night. Overall, CPAP therapy lowered DBP by &minus;2.2 mmHg (95% CI, &minus;3.9 to 0.4; P=.014), for an approximate decrease of &minus;0.5 mmHg per hour of CPAP therapy (95% CI, &minus;0.89 to &minus;0.10; P=.013).Compared with gestational weeks 0 to 16, CPAP use led to a mean DBP difference of &minus;3.09 mmHg (95% CI, &minus;5.34 to &minus;0.93) at weeks 18 to 20, &minus;3.49 mmHg (95% CI, &minus;5.67 to &minus;1.31) at weeks 24 to 28, and &minus;3.03 mmHg (95% CI, &minus;5.20 to &minus;0.85) at weeks 32 to 34.The rate of preeclampsia was 20 (13.1%) out of 153 patients in the CPAP group and 35 (22.3%) out of 157 patients in the standard care group, representing a risk difference of &minus;9% (95% CI, &minus;18 to &minus;1; P=.032) and a number-needed-to-treat of 11 (95% CI, 1-21).&ldquo;Early CPAP treatment significantly lowers DBP [and mean arterial pressure] and reduces the incidence of preeclampsia and hypertensive disorders in pregnancy,&rdquo; the authors concluded. &ldquo;This [finding] raises the need for early diagnosis and treatment of OSA in high-risk pregnancies.&rdquo;Read More Recent News on <a href="https://www.docwirenews.com/page/sleep-disorders">Sleep Disorders</a> or <a href="https://www.docwirenews.com/page/neurology">Neurology</a>

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

Can CPAP Improve High-Risk Pregnancies With OSA?

Sleep Disorders

Continuous positive airway pressure therapy improved blood pressure and preeclampsia rates in high-risk pregnancies with OSA.

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe